Novartis drug Afinitor® gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors
5 September 2011 | By Novartis
The European Commission has approved Afinitor® (everolimus) tablets...
List view / Grid view
News
Astellas Pharma signs a license agreement with Evec for a fully-human antibody
5 September 2011 | By Astellas Pharma Inc.
Astellas will obtain worldwide exclusive rights...
Pfizer extends tender offer to acquire Icagen, Inc.
5 September 2011 | By Pfizer
Expiration date of its tender offer for all outstanding shares of common stock of Icagen has been extended...
Gilead to make changes in hepatitis C drug trial design
5 September 2011 | By Gilead Sciences, Inc.
Change does not affect ongoing "All Oral" clinical trials evaluating multiple direct-acting antivirals in combination...
Wyatt Technology’s Calypso GC-MALS system provides fast & accurate measurements of biomolecular interactions
2 September 2011 | By The Scott Partnership
Free application note available to download...
AstraZeneca announces top-line results from SATURN study
2 September 2011 | By AstraZeneca
SATURN measures the impact of rosuvastatin and atorvastatin on the progression of atherosclerosis in high risk patients...
Pfizer signs agreement with MIT for future Cambridge research center
2 September 2011 | By Pfizer
Facility to house cardiovascular, metabolic and endocrine disease and neuroscience research units...
Health Canada approval Remicade® for treatment of pediatric ulcerative colitis
2 September 2011 | By Janssen Inc.
New biologic treatment option approved for chronic inflammatory bowel disease...
Bayer Healthcare to acquire Pathway Medical Technologies
2 September 2011 | By Bayer HealthCare
Transaction complements business portfolio in vascular intervention technologies...
Tecan brings HP Direct Digital Titration to drug discovery biologists
1 September 2011 | By kdm communications limited
Tecan announces the commercial availability of the new HP D300 Digital Dispenser...
Sale of Astra Tech to DENTSPLY International complete
1 September 2011 | By AstraZeneca
Transaction worth $1.8 billion in cash was completed on 31 August 2011...
New data from Bristol-Myers Squibb on NULOJIX® (belatacept)
1 September 2011 | By Bristol-Myers Squibb
Data to be presented at the 2011 European Society for Organ Transplantation Congress...
ICON selected as a preferred provider for early phase clinical development by Bristol-Myers Squibb
31 August 2011 | By ICON plc
Agreement builds on existing strategic partnership for global clinical development...
Boehringer Ingelheim broadens its breast cancer trial programme for Afatinib
30 August 2011 | By Boehringer Ingelheim
Two phase II studies investigating afatinib are now open for recruitment...
NUCYNTA® ER (Tapentadol Extended-Release Tablets) receives FDA approval
29 August 2011 | By Janssen Pharmaceuticals, Inc.
NUCYNTA® ER approved for the management of moderate to severe chronic pain...
